Skip to content
Angion Biomedica Corp

Angion Biomedica Corp

ANGION IS A LATE-STAGE CLINICAL COMPANY DEVELOPING SMALL MOLECULES TARGETING ACUTE ORGAN INJURY AND CHRONIC FIBROSIS

  • about
    • executive management
    • scientific advisory board
    • board of directors
  • our science
    • organ fibrosis
    • HGF/c-met pathway
  • pipeline
    • ANG-3070
    • ANG-3777
    • ROCK2 Inhibitor
    • CYP11B2 Inhibitor
  • Investors
    • stock information
      • stock quote & chart
      • historic price lookup
    • analyst coverage
    • press releases
    • events & presentations
    • sec filings
    • governance
    • investor resources
      • investor contact
      • investor FAQs
      • email alerts
  • publications
  • careers
  • contact

RSL-HGF

June 24, 2020February 5, 2021

Combination therapy with hepatocyte growth factor and oseltamivir confers enhanced protections against influenza viral pneumonia (Narasaraju, et al)

Posted in RSL-HGF
June 24, 2020February 5, 2021

Hepatocyte growth factor in lung repair and pulmonary fibrosis (Panganiban & Day)

Posted in RSL-HGF
June 24, 2020February 5, 2021

Lung fibroblasts accelerate wound closure in human alveolar epithelial cells through hepatocyte growth factor/c-Met signaling (Ito, et al)

Posted in RSL-HGF
January 8, 2020February 5, 2021

Activation of hepatocyte growth factor receptor, c-met, in renal tubules is required for renoprotection after acute kidney injury (Zhou, et al)

Posted in RSL-HGF
January 8, 2020February 5, 2021

The discovery of Hepatocyte Growth Factor (HGF) and its significance for cell biology, life sciences and clinical medicine (Nakamura & Mizuno)

Posted in RSL-HGF
January 2, 2020February 5, 2021

Hepatocyte growth factor: From diagnosis to clinical applications (Funakoshi & Nakamura)

Posted in RSL-HGF
January 2, 2020February 5, 2021

Up-regulation of hepatocyte growth factor receptor: an amplification and targeting mechanism for hepatocyte growth factor action in acute renal failure (Liu, et al)

Posted in RSL-HGF

CATEGORIES

  • RSL-HGF
  • RSL-ALI
  • Fibrosis
  • ROCKi
  • angion publications
  • RSL-AKI
  • events

CORPORATE ADDRESS

51 Charles Lindbergh Boulevard
Uniondale, NY 11553

Navigation

  • home
  • about
  • our science
  • pipeline
  • investors
  • publications
  • careers
  • contact

© 2022 Angion. All Rights Reserved.
Legal and Privacy Policy

NEW YORK | BOSTON | AUSTRALIA